Previous 10 | Next 10 |
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) Presents At Raymond James 42nd Annual Institutional Investors Conference - Slideshow
RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Exec...
A recap for my 20/20 Vision is offered for my readers. I will share my concerns about the current market conditions. A look back at companies I have written articles about over the last three years - 2018-2020. The good, the bad and the ugly! For further details see: Fin...
RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injectio...
The FDA has approved Amphastar Pharmaceuticals' (AMPH) first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), occurring mostly in diabetes patients.The drug is also indicated as a diagnostic aid in ...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2020 Earnings Conference Call November 6, 2020 12:00 ET Company Participants Dan Dischner - Vice President of Human Resources & Corporate Communications Bill Peters - Chief Financial Officer Tony Marrs - Senior Vice President of Regulatory Affairs...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q3 2020 Earnings Call Nov 6, 2020 , 12:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals Inc (AMPH) Q3 2020 Earnings Call Tr...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2020 Earnings Conference Call November 6, 2020 11:50 AM ET Company Participants Dan Dischner - Vice President of Human Resources and Corporate Communications Bill Peters - Chief Financial Officer Tony Marrs - Senior Vice President of Regulatory Affair...
Amphastar Pharmaceuticals (AMPH): Q3 Non-GAAP EPS of $0.15 beats by $0.01; GAAP EPS of $0.08.Revenue of $83.43M (+4.1% Y/Y) misses by $7.83M.Press Release For further details see: Amphastar Pharmaceuticals EPS beats by $0.01, misses on revenue
RANCHO CUCAMONGA, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September 30, 2020. Third Quarter Highlights Net revenues o...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...